Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00655291 · ClinicalTrials.gov registry record · Phase 3
Efficacy of XP20B Following Bunionectomy Surgery
A Phase 3 study of Acute Pain, sponsored by Xanodyne Pharmaceuticals.
- Completed
- Registry status
- Phase 3
- Development phase
- 190
- Enrollment target
- 6
- Study locations
NCT00655291 is a Phase 3 study of Acute Pain that has completed, run by Xanodyne Pharmaceuticals. The registered enrollment target is 190 participants, below the 264-participant average among 50 other Acute Pain trials with a reported enrollment target (28% lower). The trial reports 6 study locations across 4 states.
The verdict
NCT00655291, a Phase 3 study of Acute Pain, has completed, sponsored by Xanodyne Pharmaceuticals.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 190 participants
- Enrollment target
- 6
- Study locations
Study Summary
The purpose of this study is to determine if XP20B is an effective treatment for the relief of pain following bunionectomy surgery.
Conditions Studied
Interventions
- DRUG Placebo
- DRUG XP20B
Study Locations (6)
Texas
- Investigative Site - Austin
- Investigative Site - Houston
- Investigative Site - San Marcos
California
- Investigatve Site - Anaheim
Maryland
- Investigative Site - Owings Mills
Utah
- Investigative Site - Salt Lake City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 190 participants |
| Start Date | 2008-04 |
| Est. Completion | 2008-08 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00655291
The ClinicalTrials.gov registry entry for NCT00655291 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 190 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 264-participant average among 50 other Acute Pain trials with a reported enrollment target (28% lower). The listed sponsor is Xanodyne Pharmaceuticals, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Acute Pain appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT00655291 reports 6 study locations spanning 4 distinct geographic areas - top geographies include Texas, California, Maryland.
Frequently Asked Questions
What is clinical trial NCT00655291 about?
NCT00655291 is a clinical study titled "Efficacy of XP20B Following Bunionectomy Surgery". The purpose of this study is to determine if XP20B is an effective treatment for the relief of pain following bunionectomy surgery.
What is the current status of trial NCT00655291?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 190 participants. The study started on 2008-04. Estimated completion is 2008-08.
What conditions does trial NCT00655291 study?
This clinical trial studies the following conditions: Acute Pain.
What interventions are being tested in trial NCT00655291?
The interventions under investigation include: Placebo (DRUG), XP20B (DRUG).
Who is sponsoring clinical trial NCT00655291?
This trial is sponsored by Xanodyne Pharmaceuticals, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00655291 being conducted?
This trial has 6 study locations across California, Maryland, Texas, Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Acute Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Efficacy of Lidocaine Patch in Acute Musculoskeletal Pain in the Emergency Department
COMPLETED · Phase 3
-
Diclofenac Patch for the Treatment of Acute Pain Due to Mild to Moderate Wrist Sprain, Strain or Contusion
COMPLETED · Phase 3
-
Erector Spinae Block Versus Surgeon Infiltration in VATS Procedures
COMPLETED · Phase 3
-
A Study of Cebranopadol for the Treatment of Acute Pain After Bunionectomy
COMPLETED · Phase 3
-
Clinical Trial Comparing Two Protocols Using Intravenous (IV) Hydromorphone
COMPLETED · Phase 3
-
Efficacy and Safety of Oxymorphone Immediate Release in Post-surgical Acute Pain
COMPLETED · Phase 3
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.